3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
26
Pain, Postoperative
17
Neoplasms
13
Lung Neoplasms
12
Brain Neoplasms
12
Depression
7
Carcinoma, Hepatocellular
7
Pain
6
Colonic Neoplasms
6
Thyroid Neoplasms
5
Stomach Neoplasms
5
Prostatic Neoplasms
5
Leiomyoma
5
Head and Neck Neoplasms
5
Agnosia
5
Ovarian Neoplasms
4
Multiple Myeloma
4
Delirium
4
Colorectal Neoplasms
4
Anxiety Disorders
4
Supratentorial Neoplasms
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Myofibroma
3
Lymphoma
3
Hemorrhage
3
Fatigue
3
Emergence Delirium
3
Chronic Pain
3
Carcinoma, Non-Small-Cell Lung
3
Interventions
Levetiracetam
6
perampanel
2
Tranexamic Acid
2
ziprasidone
1
Zolpidem
1
Warfarin
1
Vigabatrin
1
Vecuronium Bromide
1
Vancomycin
1
Tobramycin
1
Standard of Care
1
Spironolactone
1
Sodium Chloride
1
Sevelamer
1
Saline Solution
1
Rocuronium
1
Remifentanil
1
Propofol
1
Pregabalin
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Magnesium Sulfate
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Seizures
×
Saline Solution
×
Clear all
NCT04595786
2025-03-04
STAMP
Beijing Tiantan Hospital
Phase NA
Completed
228 enrolled